2025-03-21 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix®…
